{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:21:43Z","timestamp":1789021303815,"version":"build-2803163510"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,28]]},"DOI":"10.7759\/cureus.26400","type":"journal-article","created":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T19:19:55Z","timestamp":1656443995000},"source":"Crossref","is-referenced-by-count":6,"title":["Systematic Review of Focal and Salvage Cryotherapy for Prostate Cancer"],"prefix":"10.7759","author":[{"given":"Yew Fung","family":"Chin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naing","family":"Lynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Prostate cancer incidence statistics. (2020). Accessed. June 30, 2021: https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/prostate-cancer\/inci...."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcibr0905562","article-title":"The index lesion and the origin of prostate cancer","volume":"361","author":"Ahmed HU","year":"2009","unstructured":"Ahmed HU. The index lesion and the origin of prostate cancer. N Engl J Med. 2009, 361:1704-6. 10.1056\/NEJMcibr0905562","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30595-9","article-title":"Presenting symptoms of cancer and stage at diagnosis: evidence from a cross-sectional, population-based study","volume":"21","author":"Koo MM","year":"2020","unstructured":"Koo MM, Swann R, McPhail S, Abel GA, Elliss-Brookes L, Rubin GP, Lyratzopoulos G. Presenting symptoms of cancer and stage at diagnosis: evidence from a cross-sectional, population-based study. Lancet Oncol. 2020, 21:73-9. 10.1016\/S1470-2045(19)30595-9","journal-title":"Lancet Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(08)70104-9","article-title":"Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study","volume":"9","author":"Collin SM","year":"2008","unstructured":"Collin SM, Martin RM, Metcalfe C, et al.. Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study. Lancet Oncol. 2008, 9:445-52. 10.1016\/S1470-2045(08)70104-9","journal-title":"Lancet Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2007.10.003","article-title":"Screening for prostate cancer in U.S. men ACPM position statement on preventive practice","volume":"34","author":"Lim LS","year":"2008","unstructured":"Lim LS, Sherin K. Screening for prostate cancer in U.S. men ACPM position statement on preventive practice. Am J Prev Med. 2008, 34:164-70. 10.1016\/j.amepre.2007.10.003","journal-title":"Am J Prev Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0142(19971101)80:9<1857::aid-cncr26>3.0.co;2-3","article-title":"Prostate carcinoma incidence and patient mortality: the effects of screening and early detection","volume":"80","author":"Brawley OW","year":"1997","unstructured":"Brawley OW. Prostate carcinoma incidence and patient mortality: the effects of screening and early detection. Cancer. 1997, 80:9-1857. 10.1002\/(sici)1097-0142(19971101)80:9&lt;1857::aid-cncr26&gt;3.0.co;2-3","journal-title":"Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29408","article-title":"The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the Prostate-specific Antigen-era","volume":"137","author":"Jahn JL","year":"2015","unstructured":"Jahn JL, Giovannucci EL, Stampfer MJ. The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the Prostate-specific Antigen-era. Int J Cancer. 2015, 137:2795-802. 10.1002\/ijc.29408","journal-title":"Int J Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/%28SICI%291097-0142%2819980515%2982%3A10<1887%3A%3AAID-CNCR11>3.0.CO%3B2-P","article-title":"Assessment of outcome prediction models for patients with localized prostate carcinoma managed with radical prostatectomy or external beam radiation therapy","volume":"15","author":"D'Amico AV","year":"1998","unstructured":"D'Amico AV, Desjardin A, Chung A, et al.. Assessment of outcome prediction models for patients with localized prostate carcinoma managed with radical prostatectomy or external beam radiation therapy. Cancer. 1998, 15:1887-96. 10.1002\/%28SICI%291097-0142%2819980515%2982%3A10&lt;1887%3A%3AAID-CNCR11&gt;3.0.CO%3B2-P","journal-title":"Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2147\/cia.s6555","article-title":"Is there an optimal management for localized prostate cancer?","volume":"187-97","author":"Gomella L","unstructured":"Gomella L. Is there an optimal management for localized prostate cancer?. 2010. 5, 187-97:10.2147\/cia.s6555. 10.2147\/cia.s6555","journal-title":"2010"},{"key":"ref10","unstructured":"Prostate cancer. diagnosis and management. (2019). Accessed: December 15, 2021: https:\/\/www.nice.org.uk\/guidance\/ng131."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606220","article-title":"10-year outcomes after monitoring surgery, or radiotherapy for localized prostate cancer","volume":"13","author":"Hamdy FC","year":"2016","unstructured":"Hamdy FC, Donovan JL, Lane JA, et al.. 10-year outcomes after monitoring surgery, or radiotherapy for localized prostate cancer. N Engl J Med. 2016, 13:1415-24. 10.1056\/NEJMoa1606220","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/pon.3138","article-title":"Evaluation of the association of prostate cancer-specific anxiety with sexual function, depression and cancer aggressiveness in men 1 year following surgical treatment for localized prostate cancer","volume":"22","author":"Tavlarides AM","year":"2013","unstructured":"Tavlarides AM, Ames SC, Diehl NN, et al.. Evaluation of the association of prostate cancer-specific anxiety with sexual function, depression and cancer aggressiveness in men 1 year following surgical treatment for localized prostate cancer. Psychooncology. 2013, 22:1328-35. 10.1002\/pon.3138","journal-title":"Psychooncology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5152\/tud.2013.002","article-title":"Complications of transrectal ultrasound-guided 12-core prostate biopsy: a single center experience with 2049 patients","volume":"39","author":"Efesoy O","year":"2013","unstructured":"Efesoy O, Bozlu M, \u00c7ayan S, Akbay E. Complications of transrectal ultrasound-guided 12-core prostate biopsy: a single center experience with 2049 patients. Turk J Urol. 2013, 39:6-11. 10.5152\/tud.2013.002","journal-title":"Turk J Urol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/s0090-4295(02)01678-3","article-title":"Targeted cryoablation of the prostate: seven-year outcomes in the primary treatment of prostate cancer","volume":"60","author":"Bahn DK","year":"2002","unstructured":"Bahn DK, Lee F, Bandalament R, et al.. Targeted cryoablation of the prostate: seven-year outcomes in the primary treatment of prostate cancer. Urology. 2002, 60:3-11. 10.1016\/s0090-4295(02)01678-3","journal-title":"Urology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2009.07.1170","article-title":"Predicting the long-term risk of prostate cancer-specific mortality after radical prostatectomy","volume":"74","author":"Stephenson A","year":"2009","unstructured":"Stephenson A, Klein E, Kattan M, Han M, Partin A. Predicting the long-term risk of prostate cancer-specific mortality after radical prostatectomy. Urology. 2009, 74:00904295. 10.1016\/j.urology.2009.07.1170","journal-title":"Urology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000117975.40782.95","article-title":"Long-term survival probability in men with clinically localized prostate cancer: a case-control, propensity modeling study stratified by race, age, treatment and comorbidities","volume":"171","author":"Tewari A","year":"2004","unstructured":"Tewari A, Johnson CC, Divine G, Crawford ED, Gamito EJ, Demers R, Menon M. Long-term survival probability in men with clinically localized prostate cancer: a case-control, propensity modeling study stratified by race, age, treatment and comorbidities. J Urol. 2004, 171:1513-9. 10.1097\/01.ju.0000117975.40782.95","journal-title":"J Urol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/s0090-4295(02)01839-3","article-title":"Prospective trial of cryosurgical ablation of the prostate: five-year results","volume":"60","author":"Donnelly BJ","year":"2002","unstructured":"Donnelly BJ, Salikan JC, Ernst DS, et al.. Prospective trial of cryosurgical ablation of the prostate: five-year results. Urology. 2002, 60:645-9. 10.1016\/s0090-4295(02)01839-3","journal-title":"Urology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1177\/153303460400300212","article-title":"Cryosurgery for tumors - a clinical overview","volume":"3","author":"Gage AA","year":"2004","unstructured":"Gage AA, Baust JG. Cryosurgery for tumors - a clinical overview. Technol Cancer Res Treat. 2004, 3:187-99. 10.1177\/153303460400300212","journal-title":"Technol Cancer Res Treat"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)61759-2","article-title":"Lethal freezing temperatures of the surgical capsule and cryosurgery of the prostate","volume":"1016","author":"Dow JA","year":"1970","unstructured":"Dow JA, Coughlin D, Waterhouse K. Lethal freezing temperatures of the surgical capsule and cryosurgery of the prostate. J Urol. 1970, 1016:0022-5347. 10.1016\/S0022-5347(17)61759-2","journal-title":"J Urol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/014107680109400416","article-title":"The history of cryosurgery","volume":"94","author":"Cooper SM","year":"2001","unstructured":"Cooper SM, Dawber RP. The history of cryosurgery. J R Soc Med. 2001, 94:196-201. 10.1177\/014107680109400416","journal-title":"J R Soc Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cryobiol.2013.11.001","article-title":"Mechanisms of cryoablation: clinical consequences on malignant tumors","volume":"68","author":"Baust JG","year":"2014","unstructured":"Baust JG, Gage AA, Bjerklund Johansen TE, Baust JM. Mechanisms of cryoablation: clinical consequences on malignant tumors. Cryobiology. 2014, 68:1-11. 10.1016\/j.cryobiol.2013.11.001","journal-title":"Cryobiology"},{"key":"ref22","article-title":"Cryosurgery - A review of recent advances and current issues","volume":"23","author":"Baust J","year":"2002","unstructured":"Baust J, Gage AA. Cryosurgery - A review of recent advances and current issues. Cryo Letters. 2002, 23:69-78.","journal-title":"Cryo Letters"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01489","article-title":"Comparing the oncological outcomes of cryoablation vs. radical prostatectomy in low-intermediate risk localized prostate cancer","volume":"10","author":"Guo XX","year":"2020","unstructured":"Guo XX, Liu SJ, Wang M, et al.. Comparing the oncological outcomes of cryoablation vs. radical prostatectomy in low-intermediate risk localized prostate cancer. Front Oncol. 2020, 10:1489. 10.3389\/fonc.2020.01489","journal-title":"Front Oncol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.7150\/jca.38323","article-title":"Cryotherapy shows no inferiority compared with radical Prostatectomy for low-risk and intermediate-risk localized Prostate Cancer: a real-world study from the SEER database","volume":"11","author":"Jin K","year":"2020","unstructured":"Jin K, Qiu S, Zheng X, et al.. Cryotherapy shows no inferiority compared with radical Prostatectomy for low-risk and intermediate-risk localized Prostate Cancer: a real-world study from the SEER database. J Cancer. 2020, 11:5738-45. 10.7150\/jca.38323","journal-title":"J Cancer"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.acuro.2019.10.003","article-title":"Whole and hemi-gland cryoablation for primary localized prostate cancer: short and medium-term oncological and functional outcomes","volume":"44","author":"Bossier R","year":"2020","unstructured":"Bossier R, Sanguedolce F, Territo A, et al.. Whole and hemi-gland cryoablation for primary localized prostate cancer: short and medium-term oncological and functional outcomes. Actas Urol Esp (Engl Ed). 2020, 44:172-8. 10.1016\/j.acuro.2019.10.003","journal-title":"Actas Urol Esp (Engl Ed)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-015-4686-x","article-title":"Comparisons of oncological and functional outcomes between primary whole-gland cryoablation and high-intensity focused ultrasound for localized prostate cancer","volume":"23","author":"Liu YY","year":"2016","unstructured":"Liu YY, Chiang PH. Comparisons of oncological and functional outcomes between primary whole-gland cryoablation and high-intensity focused ultrasound for localized prostate cancer. Ann Surg Oncol. 2016, 23:328-34. 10.1245\/s10434-015-4686-x","journal-title":"Ann Surg Oncol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2021.04.008","article-title":"Long-term outcomes of focal cryotherapy for low- to intermediate-risk prostate cancer: results and matched pair analysis with active surveillance [PREPRINT]","author":"Marra G","year":"2021","unstructured":"Marra G, Soeterik T, Oreggia D, et al.. Long-term outcomes of focal cryotherapy for low- to intermediate-risk prostate cancer: results and matched pair analysis with active surveillance [PREPRINT]. Eur Urol Focus. 2021, 10.1016\/j.euf.2021.04.008","journal-title":"Eur Urol Focus"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1177\/1557988318781731","article-title":"Comparative effectiveness of conservative management compared to cryotherapy in localized prostate cancer patients","volume":"12","author":"Shah S","year":"2018","unstructured":"Shah S, Young HN, Cobran EK. Comparative effectiveness of conservative management compared to cryotherapy in localized prostate cancer patients. Am J Mens Health. 2018, 12:1681-91. 10.1177\/1557988318781731","journal-title":"Am J Mens Health"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2016.11.008","article-title":"Magnetic resonance imaging-transrectal ultrasound fusion focal cryotherapy of the prostate: a prospective development study","volume":"35","author":"Valerio M","year":"2017","unstructured":"Valerio M, Shah TT, Shah P, Mccartan N, Emberton M, Arya M, Ahmed HU. Magnetic resonance imaging-transrectal ultrasound fusion focal cryotherapy of the prostate: a prospective development study. Urol Oncol. 2017, 35:150.e1-7. 10.1016\/j.urolonc.2016.11.008","journal-title":"Urol Oncol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1002\/pros.23406","article-title":"Avoidance of androgen deprivation therapy in radiorecurrent prostate cancer as a clinically meaningful endpoint for salvage cryoablation","volume":"77","author":"Ginsburg KB","year":"2017","unstructured":"Ginsburg KB, Elshafei A, Yu C, Jones JS, Cher ML. Avoidance of androgen deprivation therapy in radiorecurrent prostate cancer as a clinically meaningful endpoint for salvage cryoablation. Prostate. 2017, 77:1446-50. 10.1002\/pros.23406","journal-title":"Prostate"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference","volume":"65","author":"Roach M 3rd","year":"2006","unstructured":"Roach M 3rd, Hanks G, Thames H Jr, Schellhammer P, Shipley WU, Sokol GH, Sandler H. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys. 2006, 65:965-74. 10.1016\/j.ijrobp.2006.04.029","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.7983","article-title":"Cryosurgery versus primary androgen deprivation therapy for locally recurrent prostate cancer after primary radiotherapy: a propensity-matched survival analysis","volume":"12","author":"Bauman G","year":"2020","unstructured":"Bauman G, Ding K, Chin J, et al.. Cryosurgery versus primary androgen deprivation therapy for locally recurrent prostate cancer after primary radiotherapy: a propensity-matched survival analysis. Cureus. 2020, 12:e7983. 10.7759\/cureus.7983","journal-title":"Cureus"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2020.12.008","article-title":"A systematic review of focal ablative therapy for clinically localised prostate cancer in comparison with standard management options: limitations of the available evidence and recommendations for clinical practice and further research","volume":"4","author":"Bates AS","year":"2021","unstructured":"Bates AS, Ayers J, Kostakopoulos N, et al.. A systematic review of focal ablative therapy for clinically localised prostate cancer in comparison with standard management options: limitations of the available evidence and recommendations for clinical practice and further research. Eur Urol Oncol. 2021, 4:405-23. 10.1016\/j.euo.2020.12.008","journal-title":"Eur Urol Oncol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23161","article-title":"Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes","volume":"112","author":"Agarwal PK","year":"2008","unstructured":"Agarwal PK, Sadetsky N, Konety BR, Resnick MI, Carroll PR. Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes. Cancer. 2008, 112:307-14. 10.1002\/cncr.23161","journal-title":"Cancer"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2019.06.004","article-title":"Biochemical recurrence in prostate cancer: the European Association of Urology Prostate Cancer Guidelines Panel recommendations","volume":"6","author":"Van den Broeck T","year":"2020","unstructured":"Van den Broeck T, van den Bergh RC, Briers E, et al.. Biochemical recurrence in prostate cancer: the European Association of Urology Prostate Cancer Guidelines Panel recommendations. Eur Urol Focus. 2020, 6:231-4. 10.1016\/j.euf.2019.06.004","journal-title":"Eur Urol Focus"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2018.11.052","article-title":"Use of MRI-guided biopsy for selection and follow-up of men undergoing Hemi-gland cryoablation of prostate cancer","volume":"126","author":"Zhou SR","year":"2019","unstructured":"Zhou SR, Simopoulos DN, Jayadevan R, et al.. Use of MRI-guided biopsy for selection and follow-up of men undergoing Hemi-gland cryoablation of prostate cancer. Urology. 2019, 126:158-64. 10.1016\/j.urology.2018.11.052","journal-title":"Urology"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2019.05.014","article-title":"Salvage prostate cryoablation for the management of local recurrence after primary cryotherapy: a retrospective analysis of functional and intermediate-term oncological outcomes associated with a second therapeutic freeze","volume":"17","author":"Aminsharifi A","year":"2019","unstructured":"Aminsharifi A, Jibara G, Tsivian E, Tsivian M, Elshafei A, Polascik TJ. Salvage prostate cryoablation for the management of local recurrence after primary cryotherapy: a retrospective analysis of functional and intermediate-term oncological outcomes associated with a second therapeutic freeze. Clin Genitourin Cancer. 2019, 17:e831-6. 10.1016\/j.clgc.2019.05.014","journal-title":"Clin Genitourin Cancer"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.6244","article-title":"Oncological outcomes of salvage cryotherapy after primary radiation therapy vs. primary cryotherapy: 10-year experience at a large Canadian referral center","volume":"14","author":"Bain A","year":"2020","unstructured":"Bain A, Kinnaird A, McLarty R, Senthilselvan A, Todd G, Chetner MP. Oncological outcomes of salvage cryotherapy after primary radiation therapy vs. primary cryotherapy: 10-year experience at a large Canadian referral center. Can Urol Assoc J. 2020, 14:E604-6. 10.5489\/cuaj.6244","journal-title":"Can Urol Assoc J"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.diii.2019.07.001","article-title":"Salvage cryoablation for local recurrence of prostatic cancer after curative therapy","volume":"100","author":"Barat M","year":"2019","unstructured":"Barat M, Colleter L, Mongiat-Artus P, et al.. Salvage cryoablation for local recurrence of prostatic cancer after curative therapy. Diagn Interv Imaging. 2019, 100:679-87. 10.1016\/j.diii.2019.07.001","journal-title":"Diagn Interv Imaging"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2017.10.029","article-title":"Prospective outcome analysis of the safety and efficacy of partial and complete cryoablation in organ-confined prostate cancer","volume":"112","author":"Barqawi AB","year":"2018","unstructured":"Barqawi AB, Huebner E, Krughoff K, O'Donnell CI. Prospective outcome analysis of the safety and efficacy of partial and complete cryoablation in organ-confined prostate cancer. Urology. 2018, 112:126-31. 10.1016\/j.urology.2017.10.029","journal-title":"Urology"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2016.04.080","article-title":"Long-term oncologic outcomes of salvage cryoablation for radio-recurrent prostate cancer","volume":"196","author":"Siddiqui KM","year":"2016","unstructured":"Siddiqui KM, Billia M, Al-Zahrani A, et al.. Long-term oncologic outcomes of salvage cryoablation for radio-recurrent prostate cancer. J Urol. 2016, 196:1105-11. 10.1016\/j.juro.2016.04.080","journal-title":"J Urol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1177\/0391560317749425","article-title":"Comparative results of cryoablation and laparoscopic radical prostatectomy in the treatment of localized prostate cancer","volume":"85","author":"Chinenov DV","year":"2018","unstructured":"Chinenov DV, Rapoport LM, Shpot EV, Enikeev DV, Chernov YN, Taratkin MS, Korolev DO. Comparative results of cryoablation and laparoscopic radical prostatectomy in the treatment of localized prostate cancer. Urologia. 2018, 85:68-72. 10.1177\/0391560317749425","journal-title":"Urologia"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000001133","article-title":"Hemigland cryoablation of clinically significant prostate cancer: intermediate-term followup via magnetic resonance imaging guided biopsy","volume":"204","author":"Chuang R","year":"2020","unstructured":"Chuang R, Kinnaird A, Kwan L, et al.. Hemigland cryoablation of clinically significant prostate cancer: intermediate-term followup via magnetic resonance imaging guided biopsy. J Urol. 2020, 204:941-9. 10.1097\/JU.0000000000001133","journal-title":"J Urol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2017.01.030","article-title":"Low-dose-rate brachytherapy versus cryotherapy in low- and intermediate-risk prostate cancer","volume":"98","author":"Gestaut MM","year":"2017","unstructured":"Gestaut MM, Cai W, Vyas S, et al.. Low-dose-rate brachytherapy versus cryotherapy in low- and intermediate-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2017, 98:101-7. 10.1016\/j.ijrobp.2017.01.030","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2017.1306121","article-title":"Salvage focal cryosurgery may delay use of androgen deprivation therapy in cryotherapy and radiation recurrent prostate cancer patients","volume":"33","author":"Kongnyuy M","year":"2017","unstructured":"Kongnyuy M, Berg CJ, Kosinski KE, Habibian DJ, Schiff JT, Corcoran AT, Katz AE. Salvage focal cryosurgery may delay use of androgen deprivation therapy in cryotherapy and radiation recurrent prostate cancer patients. Int J Hyperthermia. 2017, 33:810-3. 10.1080\/02656736.2017.1306121","journal-title":"Int J Hyperthermia"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-016-1339-3","article-title":"Salvage cryotherapy with third-generation technology for locally recurrent prostate cancer after radiation therapy","volume":"48","author":"Lian H","year":"2016","unstructured":"Lian H, Yang R, Lin T, Wang W, Zhang G, Guo H. Salvage cryotherapy with third-generation technology for locally recurrent prostate cancer after radiation therapy. Int Urol Nephrol. 2016, 48:1461-6. 10.1007\/s11255-016-1339-3","journal-title":"Int Urol Nephrol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.4081\/aiua.2017.2.97","article-title":"Cryotherapy for low risk prostate cancer, oncological and functional medium term outcomes: a three center prospective study","volume":"89","author":"Lucan VC","year":"2017","unstructured":"Lucan VC, Lugnani F, Buttic\u00e8 S, et al.. Cryotherapy for low risk prostate cancer, oncological and functional medium term outcomes: a three center prospective study. Arch Ital Urol Androl. 2017, 89:97-101. 10.4081\/aiua.2017.2.97","journal-title":"Arch Ital Urol Androl"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1080\/13685538.2020.1796960","article-title":"Primary cryotherapy for localized prostate cancer treatment","volume":"23","author":"Mercader C","year":"2020","unstructured":"Mercader C, Musquera M, Franco A, Alcaraz A, Ribal MJ. Primary cryotherapy for localized prostate cancer treatment. Aging Male. 2020, 23:1460-6. 10.1080\/13685538.2020.1796960","journal-title":"Aging Male"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.6676","article-title":"Does adding local salvage ablation therapy provide survival advantage for patients with locally recurrent prostate cancer following radiotherapy? Whole gland salvage ablation post-radiation failure in prostate cancer","volume":"15","author":"Nair SM","year":"2021","unstructured":"Nair SM, Warner A, Lavi A, Rodrigues G, Chin JL. Does adding local salvage ablation therapy provide survival advantage for patients with locally recurrent prostate cancer following radiotherapy? Whole gland salvage ablation post-radiation failure in prostate cancer. Can Urol Assoc J. 2021, 15:123-9. 10.5489\/cuaj.6676","journal-title":"Can Urol Assoc J"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2018.09.004","article-title":"Primary whole-gland cryoablation for prostate cancer: biochemical failure and clinical recurrence at 5.6 years of follow-up","volume":"75","author":"Oishi M","year":"2019","unstructured":"Oishi M, Gill IS, Ashrafi AN, et al.. Primary whole-gland cryoablation for prostate cancer: biochemical failure and clinical recurrence at 5.6 years of follow-up. Eur Urol. 2019, 75:208-14. 10.1016\/j.eururo.2018.09.004","journal-title":"Eur Urol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.7812\/TPP\/18-153","article-title":"Salvage cryoablation for radiorecurrent prostate cancer: initial experience at a regional health care system","volume":"23","author":"Safavy S","year":"2019","unstructured":"Safavy S, Jabaji RB, Lu SM, Slezak JM, Cosmatos HA, Williams SG, Finley DS. Salvage cryoablation for radiorecurrent prostate cancer: initial experience at a regional health care system. Perm J. 2019, 23:18-153. 10.7812\/TPP\/18-153","journal-title":"Perm J"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2018.12.030","article-title":"Early-medium-term outcomes of primary focal cryotherapy to treat nonmetastatic clinically significant prostate cancer from a prospective multicentre registry","volume":"76","author":"Shah TT","year":"2019","unstructured":"Shah TT, Peters M, Eldred-Evans D, et al.. Early-medium-term outcomes of primary focal cryotherapy to treat nonmetastatic clinically significant prostate cancer from a prospective multicentre registry. Eur Urol. 2019, 76:98-105. 10.1016\/j.eururo.2018.12.030","journal-title":"Eur Urol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.purol.2017.09.009","article-title":"Salvage cryotherapy of prostate cancer after failed external radiotherapy and brachytherapy: Morbidity and mid-term oncological results (Article in French)","volume":"28","author":"Gevorgyan A","year":"2018","unstructured":"Gevorgyan A, H\u00e9tet JF, Robert M, Duchattelle-Dussaule V, Corno L, Boulay I, Baumert H. Salvage cryotherapy of prostate cancer after failed external radiotherapy and brachytherapy: Morbidity and mid-term oncological results (Article in French). Prog Urol. 2018, 28:291-301. 10.1016\/j.purol.2017.09.009","journal-title":"Prog Urol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2019.11.009","article-title":"Salvage focal cryotherapy offers similar short-term oncologic control and improved urinary function compared with salvage whole gland cryotherapy for radiation-resistant or recurrent prostate cancer","volume":"18","author":"Tan WP","year":"2020","unstructured":"Tan WP, ElShafei A, Aminsharifi A, Khalifa AO, Polascik TJ. Salvage focal cryotherapy offers similar short-term oncologic control and improved urinary function compared with salvage whole gland cryotherapy for radiation-resistant or recurrent prostate cancer. Clin Genitourin Cancer. 2020, 18:e260-5. 10.1016\/j.clgc.2019.11.009","journal-title":"Clin Genitourin Cancer"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2020.03.007","article-title":"Early comparative toxicity outcomes of patients with prostate cancer receiving initial cryotherapy and radiotherapy salvage","volume":"19","author":"Jiang C","year":"2021","unstructured":"Jiang C, Godette K, Hall WA, et al.. Early comparative toxicity outcomes of patients with prostate cancer receiving initial cryotherapy and radiotherapy salvage. Clin Genitourin Cancer. 2021, 19:267-70.e1. 10.1016\/j.clgc.2020.03.007","journal-title":"Clin Genitourin Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/82704-systematic-review-of-focal-and-salvage-cryotherapy-for-prostate-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:38:27Z","timestamp":1707507507000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/82704-systematic-review-of-focal-and-salvage-cryotherapy-for-prostate-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,28]]},"references-count":55,"URL":"https:\/\/doi.org\/10.7759\/cureus.26400","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,28]]}}}